Page last updated: 2024-10-25

2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone and Leukemia

2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone has been researched along with Leukemia in 1 studies

2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone: ubiquinol analog
6-decylubiquinone : A member of the class of 1,4-benzoquinones that is 2,3-dimethoxybenzoquinone which has been substituted at positions 5 and 6 by decyl and methyl groups.

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fash, DM1
Khdour, OM1
Sahdeo, SJ1
Goldschmidt, R1
Jaruvangsanti, J1
Dey, S1
Arce, PM1
Collin, VC1
Cortopassi, GA1
Hecht, SM1

Other Studies

1 other study available for 2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone and Leukemia

ArticleYear
Effects of alkyl side chain modification of coenzyme Q10 on mitochondrial respiratory chain function and cytoprotection.
    Bioorganic & medicinal chemistry, 2013, Apr-15, Volume: 21, Issue:8

    Topics: Animals; Cattle; Cell Line; Cell Line, Tumor; Cytoprotection; Electron Transport; Humans; Leukemia;

2013